Ce site respecte les principes de la charte HONcode.
Vérifiez ici.
1. Hamel-Desnos C., Gérard J-L., Desnos P. Laser endoveineux hors bloc opératoire : étude franco-suisse rétrospective multicentrique de 1700 cas. Phlébologie 2009, 62, 1. 19-27
2. Hamel-Desnos C., Gérard J-L., Desnos P. Endovenous laser procedure in a clinic room: feasibility and side effects study of 1700 cases. Phlebology 2009; 24:125–130.
3. Magi G, Antonelli P, Nardoianni V. Trattamenti endovasali conservativi: EVLT- Terapia Laser Endovenoso. Cenésthesis 2002;3:36-42.
4. Navarro L, Min R, Bonè C. Endovenous laser: a new minimally invasive method of treatment for varicose veins preliminary observations using an 810 nm diode laser. Dermatol Surg 2001;27:117-22.
5. Min R, Khilnani N, Zimmet S. Endovenous laser treatment of saphenous vein reflux: long-term results. J Vasc Interv Radiol 2003;14:991-6.
6. Perrin M. Traitement endoluminal des varices des membres inférieurs par laser endoveineux et radiofréquence. Revue de la littérature au 1er mars 2004. Phlébologie 2004;57:125-33.
7. Winterborn RJ, Foy C, Earnshow JJ. Causes of varicose vein recurrence: late results of a randomised controlled trial of stripping the long saphenous vein. J Vasc Surg 2004;40:634-9.
8. Chandler JG, Pichot O, Sessa C, Schuller-Petrovic S, Osse FJ, Bergan JJ. Defining the role of extended saphenofemoral junction ligation: a prospective comparative study. J Vasc Surg 2000;32:941-53.
9. Bergan JJ. What is neovascularization and why is it prevalent after high ligation and stripping ? IVC 2005, Third International Vein Congress: In-Office Techniques, 2005, April 14-16, Miami, FL.
10. Agus GB. The Italian endovenous-Laser working group IEWG: rational and objectives. In: Becquemin J-P, Alimi SA, Watelet J editors. Controversies and updates in vascular surgery. Torino: Minerva Medica; 2005.p. 312-3.
11. Howes N, Chagla L, Thorpe M, McCulloch P. Surgical practice in evidence based. Br J Surg 1997;84:1220-3.
12. TASC Vascular Registry Data. J Vasc Surg 2000;31 (1 Part 2):S261-3.
13. Gertler JP, Brown GB. Strategic issues for biomedical technology development. J Vasc Surg 2002;36:649-54.
14. 15th World Congress UIP 2005 Proceedings. Int Angiol 2005;24 (1 Suppl 3):1-213.
15. Agus GB, Allegra C, Antignani PL, Arpaia G, Bianchini G, Bonadeo P et al. Guidelines for the diagnosis and therapy of diseases of the veins and lymphatic vessels. Evidence-based report by the Italian College of Phlebology. Int Angiol 2005;24:107-59.
16. Glovizcki P. Credentialing, quality control, and education. Endovasc Today 2004;Suppl 1:28-9.
17. Agus G. B., Mancini S., Magi G. The first 1 000 cases of Italian Endovenous-laser Working Group (IEWG). Rationale, and long-term outcomes for the 1999-2003 period. Int Angiol 2006;25:209-215.
1. Hamel-Desnos C.M., J-L Gillet J-L., Desnos P.R., Allaert F-A. Sclerotherapy of varicose veins in patients with documented thrombophilia : a prospective controlled randomized study of 105 cases. Phlebology 2009;24:176–182.
2. Hamel-Desnos C. La mousse, un « objet fragile » (Foam is a ‘‘delicate matter’’). Journal des Maladies Vasculaires (2009) 34, 243-246
3. Hamel-Desnos C., Allaert F.A. Liquid versus foam sclerotherapy. Phlebology 2009;24:240-246
4. Hamel-Desnos C.M., Guias B.J., Desnos P.R., Mesgard A. Foam sclerotherapy of the saphenous veins: randomized controlled trial with or without compression. EJVES 2009 in press
5. Hamel-Desnos C., Ouvry P., Bénigni J-P., Boitelle G., Schadeck M., Desnos P., Allaert F-A. Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: a Randomised, Double-Blind Trial with 2 Year-Follow-Up. « The 3/1 Study ». Eur J Vasc Endovasc Surg 2007; 34: 723-9.
6. Hamel-Desnos C., Desnos P., Wollmann JC, Ouvry P., Mako S., Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol. Surg. 2003; 29: 1170-5.
7. Hamel-Desnos C., Desnos P., Ouvry P. Nouveautés thérapeutiques dans la prise en charge de la maladie variqueuse. Echo-sclérothérapie et mousse. Phlébologie 2003, 56, N°1, 41-8.
8. Hamel-Desnos C., Desnos P. Echo-Sklerotherapie und Schaum. Vasomed 2003, 15. Jahrgang N°4, 137.
9. Hamel-Desnos C., Desnos P. L’échosclérothérapie à la mousse en 2004. Technique de la ponction-injection directe. Phlébologie 2004, 57, N°3
10. Hamel-Desnos C., Ramelet A-A., Guias B., Desnos P. Efficacité des mousses de sclérosants : synthèse des principaux essais cliniques publiés. Angéiologie 2004, vol 56, n°2.
11. Hamel-Desnos C., Desnos P., Guias B., Welche Konzentration und welches Volumen sind für die Schaumsklerosierung notwending ? Jousse S., Bressolette L. Vasomed 2006. 18. Jahrgang. 20-21.
12. Hamel-Desnos C., Desnos P., Guias B. Sclérothérapie mousse et Thrombophilie. Phlébologie 2005, 58, N°4, 327-37.
13. Hamel-Desnos C., Guias G. (2), Jousse S.(2), Desnos P., Bressollette L. Echosclérothérapie à la mousse par ponction-injection directe à l’aiguille : techniques et doses. J Mal Vasc 2006 ; 31, 4, 180-9.
14. Hamel-Desnos C. et coll. Etude comparative Doppler pulsé-Doppler continu sans analyse spectrale en obstétrique. Journal des Maladies Vasculaires (Paris), Masson, 1989, 14, 32-38.
15. Hamel-Desnos C., Philippart P., Desnos P., Levy G. Intérêt de l'étude vélocimétrique des artères utérines dans l'hématome rétro-placentaire. Revue Française de Gynécologie et d'Obstétrique, 1990, 85, 11, 638 - 643.
16. Hamel-Desnos C., Allart J.M., Leconte E., Levy G. Herlicoviez M. Doppler pathologique aux artères utérines et altérations histologiques du placenta. Revue Française de Gynécologie Obstétrique, 1993, 88, 11, 556-558.
Ce site respecte les principes de la charte HONcode.
Vérifiez ici.